Rheumatoid arthritis and the prevalence of diabetic retinopathy.

Neal Barney // Publications // Sheibani Lab // Aug 01 2015

PubMed ID: 25731768

Author(s): Bartels CM, Wong JC, Johnson SL, Thorpe CT, Barney NP, Sheibani N, Smith MA. Rheumatoid arthritis and the prevalence of diabetic retinopathy. Rheumatology (Oxford). 2015 Aug;54(8):1415-9. doi: 10.1093/rheumatology/kev012. Epub 2015 Mar 2. PMID 25731768

Journal: Rheumatology (Oxford, England), Volume 54, Issue 8, Aug 2015

OBJECTIVE RA increases vascular disease and angiogenesis, yet a 1964 Lancet report paradoxically linked RA to lower diabetic retinopathy. Our objective was to examine RA as a risk factor for diabetic retinopathy compared with other vascular risk factors.

METHODS This cohort study compared the prevalence of diabetic retinopathy in diabetes patients with and without RA in a 5% Medicare sample. We analysed the impact of RA on the prevalence of diabetic retinopathy using multivariate logistic regression calculating adjusted rate ratios (ARRs) controlling for sociodemographics, co-morbidity and health utilization. Sensitivity analysis examined eye exam rates.

RESULTS Among 256 331 Medicare diabetes patients, 5572 (2%) had RA. Diabetic retinopathy was less prevalent in patients with RA compared with those without RA (13.7% vs 16.1%, P ≤ 0.01). Compared with patients without RA, the adjusted model demonstrated that patients with diabetes and RA were 28% less likely to have diabetic retinopathy and 4% more likely to receive an eye exam [ARR 0.72 (95% CI 0.67, 0.77), ARR 1.04 (95% CI 1.02, 1.06)].

CONCLUSION Findings support the 1964 paradox observing decreased diabetic retinopathy in patients with RA. These findings pose new questions regarding whether RA physiology or treatments protect against diabetic retinopathy and how intraocular factors vary in contrast to adverse vascular changes elsewhere.

© The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.